IL6R and neoplasm: Another example on the complexity of tumor immunity and chronic inflammation in tumor is a recent study demonstrating that, blocking IL-6 trans-signaling could promote tumor growth, therefore IL-6R inhibitor therapy might not be suitable for GBC or other malignancies associated with bile metabolism29.